Literature DB >> 12933514

Product limit estimation for infectious disease data when the diagnostic test for the outcome is measured with uncertainty.

B A Richardson1, J P Hughes.   

Abstract

Low sensitivity and/or specificity of a diagnostic test for outcome results in biased estimates of the time to first event using product limit estimation. For example, if a test has low specificity, estimates of the cumulative distribution function (cdf) are biased towards time zero, while estimates of the cdf are biased away from time zero if a test has low sensitivity. In the context of discrete time survival analysis for infectious disease data, we develop self-consistent algorithms to obtain unbiased estimates of the time to first event when the sensitivity and/or specificity of the diagnostic test for the outcome is less than 100%. Two examples are presented. The first involves estimating time to first detection of HIV-1 infection in infants in a randomized clinical trial, and the second involves estimating time to first Neisseria gonorrhoeae infection in a cohort of Kenyan prostitutes.

Entities:  

Year:  2000        PMID: 12933514     DOI: 10.1093/biostatistics/1.3.341

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  11 in total

1.  Nonparametric and Semiparametric Analysis of Current Status Data Subject to Outcome Misclassification.

Authors:  Victor G Sal Y Rosas; James P Hughes
Journal:  Stat Commun Infect Dis       Date:  2010-04-21

2.  Assessing treatment effects with surrogate survival outcomes using an internal validation subsample.

Authors:  Jarcy Zee; Sharon X Xie
Journal:  Clin Trials       Date:  2015-05-14       Impact factor: 2.486

3.  Methods for Employing Information About Uncertainty of Ascertainment of Events in Clinical Trials.

Authors:  Yiming Chen; John Lawrence; H M James Hung; Norman Stockbridge
Journal:  Ther Innov Regul Sci       Date:  2020-09-01       Impact factor: 1.778

4.  Interval-censored data with misclassification: a Bayesian approach.

Authors:  Magda Carvalho Pires; Enrico Antônio Colosimo; Guilherme Augusto Veloso; Raquel de Souza Borges Ferreira
Journal:  J Appl Stat       Date:  2020-04-16       Impact factor: 1.416

5.  Nonparametric discrete survival function estimation with uncertain endpoints using an internal validation subsample.

Authors:  Jarcy Zee; Sharon X Xie
Journal:  Biometrics       Date:  2015-04-27       Impact factor: 2.571

6.  Incorporating validation subsets into discrete proportional hazards models for mismeasured outcomes.

Authors:  Amalia S Magaret
Journal:  Stat Med       Date:  2008-11-20       Impact factor: 2.373

Review 7.  Statistical modeling of Huntington disease onset.

Authors:  Tanya P Garcia; Karen Marder; Yuanjia Wang
Journal:  Handb Clin Neurol       Date:  2017

8.  Estimating Time of Infection Using Prior Serological and Individual Information Can Greatly Improve Incidence Estimation of Human and Wildlife Infections.

Authors:  Benny Borremans; Niel Hens; Philippe Beutels; Herwig Leirs; Jonas Reijniers
Journal:  PLoS Comput Biol       Date:  2016-05-13       Impact factor: 4.475

9.  Technical evaluation of methods for identifying chemotherapy-induced febrile neutropenia in healthcare claims databases.

Authors:  Derek Weycker; Oleg Sofrygin; Kim Seefeld; Robert G Deeter; Jason Legg; John Edelsberg
Journal:  BMC Health Serv Res       Date:  2013-02-13       Impact factor: 2.655

Review 10.  Bias in logistic regression due to imperfect diagnostic test results and practical correction approaches.

Authors:  Denis Valle; Joanna M Tucker Lima; Justin Millar; Punam Amratia; Ubydul Haque
Journal:  Malar J       Date:  2015-11-04       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.